$158.63-1.22 (-0.76%)
Align Technology, Inc.
Align Technology, Inc. in the Healthcare sector is trading at $158.63 with a market capitalization of $11.3B. Wall Street consensus targets $208.60 (15 analysts), implying a +31.5% move over the next 12 months. The stock is currently 21% below its 52-week high of $200.44, remaining 7.0% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.04B↓ | $1.05B↑ | $995.69M↓ | $1.01B |
| Gross Profit | — | $736.59M↑ | $683.59M↑ | $639.20M↓ | $708.12M |
| Operating Income | — | $172.59M↑ | $158.88M↑ | $128.13M↓ | $163.03M |
| Net Income | — | $112.77M↓ | $135.76M↑ | $56.75M↓ | $124.61M |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package...

Align Technology stock has delivered a steeply negative 5 year share price performance, yet current valuation checks suggest the market price may now be below what its cash flows imply. At the same time, traditional market multiples look roughly in line with peers, which leaves investors weighing an intrinsic value signal that points to a discount against a share price that does not screen as extreme on earnings based measures. Over the past 5 years, Align Technology shares have declined...

Align Technology (NasdaqGS:ALGN) appoints Quentin Blackford of iRhythm Technologies to its board of directors. Andrea L. Saia plans to resign from Align Technology's board after serving for more than a decade. The board change introduces new operating and strategy experience as Align Technology marks the end of Saia's long tenure during its growth as a digital dentistry leader. For investors tracking how leadership shifts can influence long term direction, it can be useful to compare Align...

Align Technology (ALGN) is back in focus after its latest earnings report, which met revenue expectations and exceeded earnings forecasts, while also including softer guidance amid pricing and economic pressures across the sector. Align Technology’s recent guidance weighed on sentiment, and the stock has fallen about 12% since the earnings release. This contributed to a 9.26% decline in the 30 day share price return, even though the 1 year total shareholder return of 14.03% remains positive...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Align Technology (NASDAQ:ALGN) and its peers.
Academic risk and quality models computed from ALGN's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 50.5% reading.
Fama-French 5-factor market beta. The five factors explain 39% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-04.